Johnson & Johnson (J&J) has agreed to pay $132 per share to acquire Intra-Cellular Therapies Inc. in a deal valued at about $14.6 billion, taking ownership of Caplyta (lumateperone), a once-daily oral ...

NDA submitted to U.S. FDA for CAPLYTA® as adjunctive treatment for major depressive disorder; if approved, CAPLYTA® has ...

Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has ...

Shares of Lululemon Athletica Inc. ( LULU-Q +0.65% ) were higher by 0.9 per cent on Monday after it raised its ...

Prepaid carriers don't offer domestic roaming. That's the line many of us has heard, but is it really true? The answer is complicated.

The hype is building for SpaceX's cellular Starlink and other smartphone-based satellite services. But Globalstar CEO Paul Jacobs questions if customers will actually pay for such services.

For a limited time ... need to pay a little extra for the cellular lines for your accessories if you claim them ($15/mo total extra). If that doesn't phase you, then this is easily one of the ...

FY2024 revenue up 7% YoY, driven by international demand. Find out why I am upgrading CTKB stock from Hold to Buy.

Paysafecard gambling enterprises work in a means where purchases hop out zero electronic impact in the transfer of cash on ...

Getting to Know Home Security Systems Your home should always be where you feel the most safe and secure. But, the sanctity ...